Showing 1 - 20 results of 326 for search '(( 59 ((a decrease) OR (_ decrease)) ) OR ((( _ der decrease ) OR ( i w decrease ))))*', query time: 0.18s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Enhanced oil recovery using hyperbranched polyglycerol polymer-coated silica nanoparticles by Elmobarak W.F.

    Published 2021
    “…dem of 89.1% for Coil = 100 mg/L and 88.6% for Coil = 4000 mg/L. …”
    Get full text
    Get full text
  5. 5
  6. 6
  7. 7

    Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: A computational approach by P., Sneha

    Published 2017
    “…Over the past years, several studies have reported the association of missense mutations in the Hepatocyte Nuclear Factor 1 Alpha (HNF1A) with MODY3. Missense mutations in the POU homeodomain (POUH) of HNF1A hinder binding to the DNA, thereby leading to a dysfunctional protein. …”
    Get full text
    Get full text
  8. 8

    Application of magnetic nanoparticles for the removal of oil from oil-in-water emulsion: Regeneration/reuse of spent particles by Elmobarak W.F.

    Published 2021
    “…The observed %Roil at a pH of 4 and Csur of 0.05 g/L was observed to be > 90 ± 0.1% and decreased by either rising the pH to 7 or increasing the Csur to 0.1 g/L. …”
    Get full text
    Get full text
  9. 9
  10. 10

    Application of Fe3O4 magnetite nanoparticles grafted in silica (SiO2) for oil recovery from oil in water emulsions by Elmobarak W.F.

    Published 2021
    “…Using an MDdose as low as 10 mg/L attained a %ηdem in the range of 93%–94.3% for O/W mixtures with Coil < 2000 mg/L, which slightly decreased to ∼90% for higher concentrations. …”
    Get full text
    Get full text
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    A computational approach for investigating the mutational landscape of RAC-alpha serine/threonine-protein kinase (AKT1) and screening inhibitors against the oncogenic E17K mutation... by Thirumal Kumar, D

    Published 2019
    “…The molecular interaction study also revealed that the co-crystallized AKT1 inhibitor N-(4-(5-(3-acetamidophenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo [4,5-b]pyridin-3-yl)benzyl)-3-fluorobenzamide (12j) exhibited a better interaction with native AKT1 compared with the E17K mutant AKT1 protein, whereas, Akti-1/2 exhibited the opposite effects, i.e., a better interaction with the E17K mutant AKT1 than the native AKT1. …”
    Get full text
    Get full text
  18. 18
  19. 19
  20. 20